Nexera Medical
Product Claims: Canada Region Canada European Union European Union

The Next "ERA" in Germ Killing Protection for Health and Safety
Health Canada Medical Device Class 1 Establishment Licence 5703.

SpectraShield N99
Maximum Reusable Antimicrobial Respiratory Protection provided by the SpectraShield™ N99 Respirator Mask, the Guardian FFP2 RD Vertical Flat Fold Respirator Mask, all the with "Dual Action" protection:
  • Continuously Kills Bacteria and Inactivates Viruses
  • Exceeds 99% plus filtration efficiency against Bacteria and Viruses
  • Kills MS-2, MRSA, Haemophilus influenza, Legionella pneumophila and Streptococcus pyogenes, TB.
  • Inactivates SARS, Bird Flu (H5N1), Influenza A, Human Rhinovirus, Adenovirus.

The SpectraShield™ Antimicrobial Respirator Masks provide:
  1. Superior filtration of N99 performance
  2. Continuous antimicrobial protection against viruses and bacteria.
  3. 99.9% filtration efficiency against viruses and bacteria as small as .03 microns.
  4. Exceeds the U.S. Center for Disease Control ("CDC") ( ) and World Health Organization ("WHO") ( ) guidelines for protection against infectious microbial threats such as Avian Influenza, SARS and Tuberculosis.
  5. Patented proven technology incorporating a U.S. Environmental Protection Agency ("EPA") approved antimicrobial agent which is embedded into the fiber for enhanced protection.
  6. Fluid Resistance which reduces the risk and meets the requirements for ASTM Fluid Resistance. ("Resistance of Medical Face Masks to Penetration by Synthetic Blood" - at a minimum pressure of 120 mm Hg.)
  7. Reduces mask odor caused by bacterial growth.
  8. Continuously self-sanitizes itself for extended use.
  9. Natural nontoxic antimicrobial agent is safe for wear.

For Regulatory Approval / Clearance by Country:

  • Canada

  • European Union
         EN149 Approved

  • Copyright © 2023 Nexera Medical. All rights reserved.